Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending April 16, 2017
Second Malignancies Post-Auto-HCT in Hodgkin Lymphoma , Biol Blood Marrow Transplant; ePub 2017 Apr 4; Pingali, et al
This Approach Could Cure Certain T-ALL Patients , Biol Blood Marrow Transplant; ePub 2017 Apr 7; Hamilton, et al
New Measure Might Better Define Efficacy Post-Transplant , Biol Blood Marrow Transplant; ePub 2017 Apr 5; Solomon, et al
Pericardial Effusion Following HCT in Children , Biol Blood Marrow Transplant; ePub 2017 Apr 5; Cox, et al
Transplant Approach Linked with Early Benefit, Biol Blood Marrow Transplant; ePub 2017 Apr 6; Anand, et al
Must reads for theWeek ending April 9, 2017
Mercaptopurine Ingestion Habits and Adherence in ALL, J Clin Oncol; ePub 2017 Mar 24; Landier, et al
Outcomes in Lower-Risk MDS Patients Evaluated , J Clin Oncol; ePub 2017 Mar 28; Park, Hamel, et al
Vancomycin-Resistant Enterococci in AML, MDS Patients, Leuk Lymphoma; ePub 2017 Mar 28; Heisel, et al
Elevated Measures Precede Classical Hodgkin Lymphoma, Cancer Epidemiol Biomarkers Prev; ePub 2017 Mar 24; Levin, et al
Rivaroxaban or Aspirin for Extended VTE Treatment, N Engl J Med; 2017 Mar 30; Weitz, Lensing, et al
Must reads for theWeek ending April 2, 2017
This is Underutilized in Older Patients with MDS, Biol Blood Marrow Transplant; ePub 2017 Mar 21; Getta, et al
Ask Light Chain Amyloidosis Patients These Questions , Am J Hematol; ePub 2017 Mar 20; Warsame, et al
Distinguishing ET from Prefibrotic Primary Myelofibrosis , Am J Hematol; ePub 2017 Mar 20; Mudireddy, et al
Predicting Relapse Risk and Survival Prior to HCT, Biol Blood Marrow Transplant; ePub 2017 Mar 16; Getta, et al
Selecting Older MDS Patients for Allo-HSCT , Cancer; ePub 2017 Mar 21; Yucel, Saliba, et al
Must reads for theWeek ending March 26, 2017
Intestinal Microbiota and Relapse After Allo-HCT, J Clin Oncol; ePub 2017 Mar 15; Peled, et al
High-Dose Flu Vaccine Use in Plasma Cell Disorders, Clin Lymphoma Myeloma Leuk; ePub 2017 Mar 7; Branagan, et al
Impact of Rhinovirus Detection in HCT Recipients, Haematologica; ePub 2017 Feb 9; Seo, et al
Everolimus Evaluated for Indolent Non-Hodgkin Lymphomas, Am J Hematol; ePub 2017 Mar 10; Bennani, et al
FDA Approves Keytruda for Classical Hodgkin Lymphoma, Merck news release; 2017 Mar 14
Must reads for theWeek ending March 19, 2017
25% of ED Costs Due to Poor Symptom Management, 2017 ASCO Quality Care Symposium; Panattoni, et al
Quantifying Cost of Care Under Oncology Care Model, 2017 ASCO Quality Care Symposium; Williams, et al
Reducing Overuse of CSFs in Lung Cancer Patients, J Oncol Pract; ePub 2017 Mar 4; Adeboyeje, et al
Clinical Pathways Led to Decreased Care Costs, J Oncol Pract; ePub 2017 Mar 4; Jackman, et al
Fewer Readmissions for Cancer Patients After Hospice, 2017 ASCO Quality Care Symposium; Mayo Manzano, et al